Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.
2.

Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.

Wilms H, Zecca L, Rosenstiel P, Sievers J, Deuschl G, Lucius R.

Curr Pharm Des. 2007;13(18):1925-8. Review.

PMID:
17584117
3.

Microglial activation and its implications in the brain diseases.

Dheen ST, Kaur C, Ling EA.

Curr Med Chem. 2007;14(11):1189-97. Review.

PMID:
17504139
4.

Role of cytokines in inflammatory process in Parkinson's disease.

Sawada M, Imamura K, Nagatsu T.

J Neural Transm Suppl. 2006;(70):373-81. Review.

PMID:
17017556
5.

Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?

Rogers J, Mastroeni D, Leonard B, Joyce J, Grover A.

Int Rev Neurobiol. 2007;82:235-46. Review.

PMID:
17678964
6.

P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases.

Takenouchi T, Sekiyama K, Sekigawa A, Fujita M, Waragai M, Sugama S, Iwamaru Y, Kitani H, Hashimoto M.

Arch Immunol Ther Exp (Warsz). 2010 Apr;58(2):91-6. doi: 10.1007/s00005-010-0069-y. Epub 2010 Feb 9. Review.

PMID:
20143170
7.

Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?

Tansey MG, Frank-Cannon TC, McCoy MK, Lee JK, Martinez TN, McAlpine FE, Ruhn KA, Tran TA.

Front Biosci. 2008 Jan 1;13:709-17. Review.

PMID:
17981581
8.

Novel anti-inflammatory therapy for Parkinson's disease.

Gao HM, Liu B, Zhang W, Hong JS.

Trends Pharmacol Sci. 2003 Aug;24(8):395-401. Review.

PMID:
12915048
9.

Inflammation and Parkinson's disease.

Wersinger C, Sidhu A.

Curr Drug Targets Inflamm Allergy. 2002 Sep;1(3):221-42. Review.

PMID:
14561187
10.

Microglia and neuroprotection: from in vitro studies to therapeutic applications.

Polazzi E, Monti B.

Prog Neurobiol. 2010 Nov;92(3):293-315. doi: 10.1016/j.pneurobio.2010.06.009. Epub 2010 Jul 4. Review.

PMID:
20609379
11.
12.

Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.

Morale MC, Serra PA, L'episcopo F, Tirolo C, Caniglia S, Testa N, Gennuso F, Giaquinta G, Rocchitta G, Desole MS, Miele E, Marchetti B.

Neuroscience. 2006;138(3):869-78. Epub 2005 Dec 5. Review.

PMID:
16337092
13.

Role of nitric oxide in inflammation-mediated neurodegeneration.

Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL, Hong JS.

Ann N Y Acad Sci. 2002 May;962:318-31. Review.

PMID:
12076984
14.

The influence of microglia on the pathogenesis of Parkinson's disease.

Long-Smith CM, Sullivan AM, Nolan YM.

Prog Neurobiol. 2009 Nov;89(3):277-87. doi: 10.1016/j.pneurobio.2009.08.001. Epub 2009 Aug 15. Review.

PMID:
19686799
15.

Effects of aging on neuroprotective and neurotoxic properties of microglia in neurodegenerative diseases.

Sawada M, Sawada H, Nagatsu T.

Neurodegener Dis. 2008;5(3-4):254-6. doi: 10.1159/000113717. Epub 2008 Mar 6. Review.

PMID:
18322405
16.

Microglia-targeted pharmacotherapy in retinal neurodegenerative diseases.

Schuetz E, Thanos S.

Curr Drug Targets. 2004 Oct;5(7):619-27. Review.

PMID:
15473251
17.

Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

Hald A, Lotharius J.

Exp Neurol. 2005 Jun;193(2):279-90. Review.

PMID:
15869932
18.

The role of glial reaction and inflammation in Parkinson's disease.

Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP.

Ann N Y Acad Sci. 2003 Jun;991:214-28. Review.

PMID:
12846989
19.

The brain as a target for inflammatory processes and neuroprotective strategies.

Skaper SD.

Ann N Y Acad Sci. 2007 Dec;1122:23-34. Review.

PMID:
18077562
20.

Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis.

Sargsyan SA, Monk PN, Shaw PJ.

Glia. 2005 Sep;51(4):241-53. Review.

PMID:
15846792

Supplemental Content

Support Center